Korsana Biosciences Statistics
Total Valuation
KRSA has a market cap or net worth of $1.42 billion. The enterprise value is $1.28 billion.
| Market Cap | 1.42B |
| Enterprise Value | 1.28B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRSA has 45.54 million shares outstanding.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +150.00% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 26.77% |
| Float | 26.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.40, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.40 |
| Quick Ratio | 17.28 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -39.95% |
| Weighted Average Cost of Capital (WACC) | 14.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.58M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +174.00% in the last 52 weeks. The beta is 1.84, so KRSA's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | +174.00% |
| 50-Day Moving Average | 31.60 |
| 200-Day Moving Average | 22.70 |
| Relative Strength Index (RSI) | 49.05 |
| Average Volume (20 Days) | 177,010 |
Short Selling Information
The latest short interest is 23,804, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 23,804 |
| Short Previous Month | 11,552 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.09% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -51.91M |
| Pretax Income | -49.08M |
| Net Income | -49.08M |
| EBITDA | n/a |
| EBIT | -51.91M |
| Earnings Per Share (EPS) | -$13.37 |
Balance Sheet
The company has $134.16 million in cash and $1.10 million in debt, with a net cash position of $133.07 million or $2.92 per share.
| Cash & Cash Equivalents | 134.16M |
| Total Debt | 1.10M |
| Net Cash | 133.07M |
| Net Cash Per Share | $2.92 |
| Equity (Book Value) | 128.51M |
| Book Value Per Share | -7.84 |
| Working Capital | 127.34M |
Cash Flow
In the last 12 months, operating cash flow was -$41.84 million and capital expenditures -$165,000, giving a free cash flow of -$42.01 million.
| Operating Cash Flow | -41.84M |
| Capital Expenditures | -165,000 |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -42.01M |
| FCF Per Share | -$0.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -42.98% |
| FCF Yield | -2.96% |
Analyst Forecast
The average price target for KRSA is $44.00, which is 41.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.00 |
| Price Target Difference | 41.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 9, 2026. It was a reverse split with a ratio of 1:7.
| Last Split Date | Sep 9, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |